Vaxcell Bio Therapeutics
KOSDAQ:323990
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
V
|
Vaxcell Bio Therapeutics
KOSDAQ:323990
|
KR |
|
C
|
Chow Tai Fook Jewellery Group Ltd
XMUN:1CT
|
HK |
|
S
|
Schneider Electric SE
XMUN:SND
|
FR |
|
Tokyo Century Corp
F:59O
|
JP |
|
Anima Holding SpA
MIL:ANIM
|
IT |
|
I
|
Ingredion Inc
SWB:CNP
|
US |
|
F
|
Fine Metal Technologies PCL
SET:FMT
|
TH |
|
C
|
CapitaLand Ascendas REIT
OTC:ACDSF
|
SG |
|
I
|
Installed Building Products Inc
SWB:2IL
|
US |
|
T
|
Thales SA
XMUN:CSF
|
FR |
|
Q
|
Qingdao Port International Co Ltd
XMUN:0QP
|
CN |
|
M
|
Monster Beverage Corp
SWB:MOB
|
US |
|
X
|
Xtb SA
WSE:XTB
|
PL |
|
DiaSorin SpA
OTC:DSRLF
|
IT |
|
M
|
Myriad Genetics Inc
F:MYD
|
US |
|
Siemens AG
F:SIE
|
DE |
|
W
|
Wellness Matrix Group Inc
OTC:WMGR
|
US |
|
M
|
MaxCyte Inc
NASDAQ:MXCT
|
US |
|
Fisher & Paykel Healthcare Corporation Ltd
F:FPLB
|
NZ |
|
N
|
NovaBay Pharmaceuticals Inc
AMEX:SDEV
|
US |
|
A
|
Afi Properties Ltd
TASE:AFPR
|
IL |
|
R
|
Rogers Corp
F:RG6
|
US |
|
Softcat PLC
LSE:SCT
|
UK |
|
Bangkok Bank PCL
SET:BBL
|
TH |
Shareholder Yield
Current shareholder yield for Vaxcell Bio Therapeutics is hidden .
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
Price
Vaxcell Bio Therapeutics
| Average Annual Return | -33.93% |
| Standard Deviation of Annual Returns | 21.95% |
| Max Drawdown | -96% |
| Market Capitalization | 101.2B KRW |
| Shares Outstanding | 23 260 000 |
| Percentage of Shares Shorted |
N/A
|
Return Decomposition
Main factors of price return
Stock Splits
Vaxcell Bio Therapeutics's latest stock split occurred on Nov 10, 2023
The company executed a 6-for-5 stock split, meaning that for every 5 shares held, investors received 6 new shares.
Before the split, Vaxcell Bio Therapeutics traded at 23999.9908 per share. Afterward, the share price was about 21250.
The adjusted shares began trading on Nov 10, 2023. This was stock split number 3 in Vaxcell Bio Therapeutics's history, following the previous one in Sep 20, 2023.